Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jana, Halamkova"'
Autor:
Michal, Rihacek, Andrea, Wagnerova, Jana, Halamkova, Lucie, Pehalova, Eva, Rihackova, Lubos, Boucek, Kateřina, Kapounková, Iva, Hrnčiříková, Igor, Kiss
Publikováno v:
In Heliyon 30 October 2024 10(20)
Autor:
Iva Benesova, Rudolf Nenutil, Adam Urminsky, Erika Lattova, Lukas Uhrik, Peter Grell, Filip Zavadil Kokas, Jana Halamkova, Zbynek Zdrahal, Borivoj Vojtesek, Milos V. Novotny, Lenka Hernychova
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Breast cancer is a highly heterogeneous disease. Its intrinsic subtype classification for diagnosis and choice of therapy traditionally relies on the presence of characteristic receptors. Unfortunately, this classification is often not suffi
Externí odkaz:
https://doaj.org/article/94832c75874a4386884dac9683301066
Autor:
Annalisa Trama, Lisa Licitra, Stefano Cavalieri, Simone Bonfarnuzzo, Paolo Baili, Antonio Ciarfella, Pablo Parente, Giovanni Almadori, Mohssen Ansarin, Almalina Bacigalupo, Philipp Baumeister, Bertrand Baujat, Paolo Bossi, Elisa Cavalera, Maria Cecilia Cercato, Francois Dieleman, Nicolas Fakhry, Virginia Ferraresi, Francesca Gaino, Danilo Galizia, Jana Halamkova, Elina Halme, Jose Hardillo, Benedikt Hofauer, Emma Kinloch, Lorenzo Livi, Laura Deborah Locati, Stefan Mattheis, Giuseppe Mercante, Aurora Mirabile, Gabriele Molteni, Ester Orlandi, Roberto Persio, Stefania Sciallero, Ludi Smeele, Marta Tagliabue, Valentino Valentini, Carla Van Harpen, Christoph Benedikt Westphalen, Laura Botta
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283071 (2023)
IntroductionCare for head and neck cancers is complex in particular for the rare ones. Knowledge is limited and histological heterogeneity adds complexity to the rarity. There is a wide consensus that to support clinical research on rare cancer, clin
Externí odkaz:
https://doaj.org/article/874785dfe26a4d4f844fd478640270be
Autor:
Jana Halamkova, Tomas Kazda, Lucie Pehalova, Roman Gonec, Sarka Kozakova, Lucia Bohovicova, Dagmar Adamkova Krakorova, Ondrej Slaby, Regina Demlova, Marek Svoboda, Igor Kiss
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The prevalence of second primary malignancies (SPMs) in the western world is continually increasing with the risk of a new primary cancer in patients with previously diagnosed carcinoma at about 20%. The aim of this retrospective analysis is
Externí odkaz:
https://doaj.org/article/4fcc073869ee41ac8e20f548ff6856ed
Autor:
Jana Halamkova, Tomas Kazda, Lucie Pehalova, Roman Gonec, Sarka Kozakova, Lucia Bohovicova, Ondrej Slaby, Regina Demlova, Marek Svoboda, Igor Kiss
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
IntroductionAll colorectal cancer (CRC) survivors have an increased risk of developing second primary malignancies (SPMs). The association between diabetes mellitus (DM) and the risk of cancer is well known. However, the role of DM and its therapy in
Externí odkaz:
https://doaj.org/article/cb39fb11acbe4c8e94d1927a67ed0395
Autor:
Tana Machackova, Petra Vychytilova-Faltejskova, Marie Madrzyk, Karolina Trachtova, Marketa Pavlikova, Jan Kotoucek, Jana Halamkova, Dagmar Al Tukmachi, Jiri Sana, Petra Pokorna, Milana Sachlova, Ondrej Slaby
Publikováno v:
Cancer Research. 83:6709-6709
Introduction: Currently used molecular diagnostic tests for colorectal cancer (CRC) are underperforming and more sensitive, non-invasive biomarkers are needed. Long non-coding RNAs (lncRNA) and microRNA (miRNA) have shown potential as diagnostic biom
This work is motivated by the scarcity of tools for accurate, unsupervised information extraction from unstructured clinical notes in computationally underrepresented languages, such as Czech. We introduce a stepping stone to a broad array of downstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f243c13daf7fdbb67bdad9b19e337e
Autor:
Pavlína Bazalová, Iva Burešová, Markéta Hadrabová, Jana Halámková, Iva Hrnčiříková, Andrea Janíková, Kateřina Kapounková (ed.), Ivan Struhár, Zora Svobodová, Marie Šimonová
Title in English: Pohybová aktivita jako účinný prostředek nefarmakologické péče v onkologii Much of the existing research confirms the assumption that regular physical activity can play a crucial role in nonpharmacological therapy and qualit
Autor:
Igor, Kiss, Zbynek, Bortlicek, Bohuslav, Melichar, Alexandr, Poprach, Jana, Halamkova, Rostislav, Vyzula, Ladislav, Dusek, Tomas, Buchler
Publikováno v:
Anticancer research. 34(2)
The aim of the present study was to describe treatment outcomes for bevacizumab in combination with chemotherapy based on data from the Czech registry of targeted therapies for metastatic colorectal cancer (mCRC).In total, 4,487 patients with mCRC wh
Autor:
Jana, Halamkova, Igor, Kiss, Zdenek, Pavlovsky, Jiri, Jarkovsky, Jiri, Tomasek, Stepan, Tucek, Lada, Hanakova, Mojmir, Moulis, Zbynek, Cech, Jirina, Zavrelova, Miroslav, Penka
Publikováno v:
Hepato-gastroenterology. 58(112)
Urokinase (uPA) is a serine protease, which together with uPAR, tPA, PAI 1 and PAI 2 forms the plasminogen activator system, a component of metastatic cascade contributing to the invasive growth and angiogenesis of malignant tumours.Both preceding th